ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIAL

被引：0
|
作者：
Burger, M. [1 ]
Thiounn, N. [2 ]
Denzinger, N. [1 ]
Malavaud, B. [3 ]
Wirth, M. [4 ]
Thueroff, J. W. [5 ]
Romics, I. [6 ]
Colombel, M. [7 ]
Solsona, E. [8 ]
Tombal, B. [9 ]
Sherman, J. [10 ]
机构：
[1] Univ Regensburg, Dept Urol, Regensburg, Germany
[2] Univ Paris 05, Dept Urol, Paris, France
[3] Paris St Joseph Hosp Trust, Dept Urol, Paris, France
[4] Univ Dresden, Dept Urol, Dresden, Germany
[5] Johannes Gutenberg Univ Mainz, Dept Urol, Mainz, Germany
[6] Semmelweis Univ, Dept Urol, H-1085 Budapest, Hungary
[7] Hop Edouard Herriot, Dept Urol, Lyon, France
[8] Inst Valenciano Oncol, Dept Urol, Valencia, Spain
[9] Clin Univ St Luc, Dept Urol, B-1200 Brussels, Belgium
[10] IDM Pharma, Dept Med, Irvine, CA USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60652-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [41] Device-assisted intravesical therapy for non-muscle invasive bladder cancer
    Hendricksen, Kees
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (01) : 94 - 100
  • [42] Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
    Serretta, Vincenzo
    Sommatino, Francesco
    Gesolfo, Cristina Scalici
    Franco, Vito
    Cicero, Giuseppe
    Allegro, Rosalinda
    UROLOGY ANNALS, 2015, 7 (01) : 21 - 25
  • [43] Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer
    Messing, Edward
    BLADDER CANCER, 2020, 6 (01) : 97 - 98
  • [44] RE-TUR plus BCG vs. upfront BCG in high-risk non-muscle invasive bladder cancer: A feasibility phase of a randomized controlled study
    Soria, F.
    Rosazza, M.
    Burger, M.
    Comperat, E.
    Liedberg, F.
    Masson-Lecomte, A.
    Mostafid, H.
    Van, Rhijn B. W.
    Shariat, S. F.
    Babjuk, M.
    Sylvester, R. J.
    Palou, J.
    Gontero, P.
    EUROPEAN UROLOGY, 2022, 81 : S241 - S241
  • [45] DETECTION OF CIRCULATING TUMOUR CELLS AS PROGNOSTIC FACTOR IN INTRAVESICAL ADJUVANT THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER
    De Berardinis, Ettore
    Busetto, Gian Maria
    Antonini, Gabriele
    Di Placido, Mariarosaria
    Nicolazzo, Chiara
    Petracca, Arianna
    Gentile, Vincenzo
    Gazzaniga, Paola
    ANTICANCER RESEARCH, 2010, 30 (04) : 1426 - 1427
  • [46] A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Patel, Sunil H.
    Gabrielson, Andrew T.
    Chan, Sin
    Schwartz, Deborah
    Collins, Connie
    Singla, Nirmish
    Trock, Bruce
    Bivalacqua, Trinity J.
    Hahn, Noah
    Kates, Max R.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E245 - E246
  • [47] A NOVEL SIMULATION MODEL OF NON-MUSCLE INVASIVE BLADDER CANCER: A PLATFORM FOR A VIRTUAL RANDOMIZED TRIAL OF CONSERVATIVE THERAPY VS CYSTECTOMY IN BCG REFRACTORY PATIENTS
    Dinh, Tuan A.
    Noah-Vanhoucke, Joyce
    Rengarajan, Badri
    Mayo, Kevin W.
    Goswami, Devesh
    Clark, Peter E.
    Kamat, Ashish M.
    Lee, Cheryl T.
    Sexton, Wade J.
    Steinberg, Gary D.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E431 - E432
  • [48] A genome-wide association study on intravesical recurrence after BCG therapy for non-muscle invasive bladder cancer
    Nagakawa, Shohei
    Shiota, Masaki
    Fujimoto, Naohiro
    Yamamoto, Yoshiaki
    Tsukahara, Shigehiro
    Matsumoto, Takashi
    Kashiwagi, Eiji
    Takeuchi, Ario
    Inokuchi, Junichi
    Uchiumi, Takeshi
    Matsuyama, Hideyasu
    Eto, Masatoshi
    CANCER SCIENCE, 2022, 113 : 1588 - 1588
  • [49] ADDING MITOMYCIN C TO BCG AS ADJUVANT INTRAVESICAL THERAPY FOR HIGH-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER: A RANDOMISED PHASE 3 TRIAL
    Chalasani, V.
    Sengupta, S.
    Stockler, M.
    McCombie, S.
    Hawks, C.
    Long, A.
    Bracken, K.
    Roncolato, F.
    Hayne, D.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 53 - 53
  • [50] THERMAL INTRAVESICAL CHEMOTHERAPY IN ADJUVANT TREATMENT OF HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Efiloglu, Ozgur
    Bayrak, Omer
    Turan, Turgay
    Kazan, Huseyin Ozgur
    Culpan, Meftun
    Cakici, Mehmet Caglar
    Erturhan, Sakip
    Yildirim, Asif
    ARCHIVOS ESPANOLES DE UROLOGIA, 2021, 74 (09): : 875 - 882
12345